Richard Close
Stock Analyst at Canaccord Genuity
(1.35)
# 3,655
Out of 5,182 analysts
154
Total ratings
34.65%
Success rate
-10.49%
Average return
Main Sectors:
Stocks Rated by Richard Close
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PHR Phreesia | Maintains: Buy | $33 → $22 | $9.62 | +128.69% | 13 | Mar 31, 2026 | |
| DCGO DocGo | Maintains: Hold | $1.5 → $1 | $0.69 | +45.39% | 9 | Mar 25, 2026 | |
| CLOV Clover Health Investments | Maintains: Buy | $3.7 → $3.2 | $2.52 | +26.98% | 7 | Mar 20, 2026 | |
| HCAT Health Catalyst | Maintains: Buy | $5 → $2 | $1.37 | +45.99% | 10 | Mar 13, 2026 | |
| PGNY Progyny | Maintains: Hold | $26 → $19 | $18.41 | +3.20% | 10 | Mar 11, 2026 | |
| TALK Talkspace | Downgrades: Hold | n/a | $5.18 | - | 3 | Mar 9, 2026 | |
| OMDA Omada Health | Maintains: Buy | $28 → $22 | $14.72 | +49.46% | 3 | Mar 6, 2026 | |
| PRVA Privia Health Group | Maintains: Buy | $34 → $35 | $24.41 | +43.38% | 10 | Feb 27, 2026 | |
| TDOC Teladoc Health | Maintains: Buy | $12 → $10 | $5.85 | +70.94% | 17 | Feb 26, 2026 | |
| LFST LifeStance Health Group | Maintains: Buy | $9 → $10 | $7.27 | +37.55% | 2 | Feb 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $54 → $30 | $25.70 | +16.73% | 7 | Feb 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $65 → $53 | $45.03 | +17.70% | 4 | Feb 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $48 → $34 | $24.66 | +37.88% | 14 | Feb 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $28 | $21.43 | +30.66% | 9 | Dec 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $16 → $9 | $3.47 | +159.37% | 13 | Nov 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $15 | $13.08 | +14.68% | 8 | Nov 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $117 → $121 | $135.75 | -10.87% | 3 | Jul 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $22 → $24 | $27.93 | -14.07% | 3 | Aug 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $79 → $95 | $65.03 | +46.09% | 9 | Apr 22, 2021 |
Phreesia
Mar 31, 2026
Maintains: Buy
Price Target: $33 → $22
Current: $9.62
Upside: +128.69%
DocGo
Mar 25, 2026
Maintains: Hold
Price Target: $1.5 → $1
Current: $0.69
Upside: +45.39%
Clover Health Investments
Mar 20, 2026
Maintains: Buy
Price Target: $3.7 → $3.2
Current: $2.52
Upside: +26.98%
Health Catalyst
Mar 13, 2026
Maintains: Buy
Price Target: $5 → $2
Current: $1.37
Upside: +45.99%
Progyny
Mar 11, 2026
Maintains: Hold
Price Target: $26 → $19
Current: $18.41
Upside: +3.20%
Talkspace
Mar 9, 2026
Downgrades: Hold
Price Target: n/a
Current: $5.18
Upside: -
Omada Health
Mar 6, 2026
Maintains: Buy
Price Target: $28 → $22
Current: $14.72
Upside: +49.46%
Privia Health Group
Feb 27, 2026
Maintains: Buy
Price Target: $34 → $35
Current: $24.41
Upside: +43.38%
Teladoc Health
Feb 26, 2026
Maintains: Buy
Price Target: $12 → $10
Current: $5.85
Upside: +70.94%
LifeStance Health Group
Feb 26, 2026
Maintains: Buy
Price Target: $9 → $10
Current: $7.27
Upside: +37.55%
Feb 18, 2026
Maintains: Buy
Price Target: $54 → $30
Current: $25.70
Upside: +16.73%
Feb 11, 2026
Maintains: Buy
Price Target: $65 → $53
Current: $45.03
Upside: +17.70%
Feb 9, 2026
Upgrades: Buy
Price Target: $48 → $34
Current: $24.66
Upside: +37.88%
Dec 17, 2025
Maintains: Hold
Price Target: $28
Current: $21.43
Upside: +30.66%
Nov 14, 2025
Maintains: Buy
Price Target: $16 → $9
Current: $3.47
Upside: +159.37%
Nov 6, 2025
Maintains: Buy
Price Target: $14 → $15
Current: $13.08
Upside: +14.68%
Jul 31, 2024
Maintains: Neutral
Price Target: $117 → $121
Current: $135.75
Upside: -10.87%
Aug 4, 2021
Maintains: Buy
Price Target: $22 → $24
Current: $27.93
Upside: -14.07%
Apr 22, 2021
Maintains: Hold
Price Target: $79 → $95
Current: $65.03
Upside: +46.09%